Previous Article | Next Article 
Journal of Bacteriology, July 2001, p. 3999-4003, Vol. 183, No. 13
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.13.3999-4003.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rebinding of Extracellular Adherence Protein Eap to
Staphylococcus aureus Can Occur through a Surface-Bound
Neutral Phosphatase
Margareta
Flock and
Jan-Ingmar
Flock*
Department of Microbiology, Pathology and
Immunology, Huddinge University Hospital, Karolinska Institutet,
S-141 86 Huddinge, Sweden
Received 27 December 2000/Accepted 9 April 2001
 |
ABSTRACT |
Extracellular adherence protein Eap secreted from
Staphylococcus aureus was previously found to enhance the
adherence of S. aureus to eukaryotic cells. This
enhancement effect is due to the ability of Eap to rebind to S. aureus and to bind to eukaryotic cells and several plasma and
matrix proteins. In this study we defined one potential binding target
for Eap on the surface of S. aureus, a surface-located
neutral phosphatase. This phosphatase lacks an LPXTG region, but around
80% is retained on the cell surface. The soluble phosphatase can form
a complex with Eap at a nonrandom molar ratio, and phosphatase activity
is retained. The phosphatase can also bind to fibronectin. The cell
surface-located portion presumably contributes to adherence of S. aureus to fibronectin.
 |
INTRODUCTION |
Staphylococcus aureus
produces at least three different fibrinogen binding proteins which are
secreted from the cells: coagulase (19), extracellular
fibrinogen binding protein Efb (1, 17), and extracellular
adherence protein Eap (2, 15). Two cell surface-associated
fibrinogen binding proteins, clumping factors Clf A (10,
11) and Clf B (13), have been shown to be the major
factors responsible for adherence to immobilized fibrinogen and are
important in promoting endocarditis (12).
Efb (15.8 kDa) has been found to be a virulence factor in experimental
wound infections because it delays wound healing (16). Antibodies against Efb have been shown to have a protective effect (9). Efb is distinct from Clf A and Clf B because it does
not promote adherence of cells to fibrinogen. It binds to a different region of fibrinogen than Clf A and forms a precipitate together with
fibrinogen due to its divalent binding to fibrinogen. Its interaction
with fibrinogen is stimulated by Ca2+ (17).
Eap (60 kDa), the focus of this study, binds to several but not all
plasma proteins, including fibrinogen, fibronectin, vitronectin, and
prothrombin. Eap is secreted, but it is only partially released from
cells; ca. 30% of Eap was found to be associated with cells and the
rest was in the supernatant both during logarithmic growth and after
overnight cultivation. We have demonstrated that externally added Eap
can bind to S. aureus. To a lesser extent, Eap can bind to
some other bacterial species. Eap has a strong tendency to form
oligomers, and due to its affinity for S. aureus cells it causes aggregation of S. aureus, which is often seen in
overnight broth cultures. Furthermore, adherence of S. aureus to fibroblasts was significantly enhanced by addition of
Eap as a result of the affinity of Eap for S. aureus, for
itself, and for a component(s) on the eukaryotic cell surface. We have
hypothesized that Eap serves as an enhancer of bacterial adherence
along with surface-located proteins, such as clumping factor,
fibronectin binding protein, vitronectin binding protein, etc.
(15). In several respects, Eap resembles internalin (InlB)
from Listeria monocytogenes, which is responsible for
internalization (3). InlB is secreted and can rebind to cells.
Eap is a member of a family of similar proteins. Eap from strain Newman
exhibited homology with an S. aureus protein designated major histocompatibility complex class II analogous protein Map. The
map gene of strain FDA 574 has been sequenced
(8). Eap exhibits extensive homology with a p70 protein
from strain Wood 46 (4, 7; National Center for
Biotechnology Information accession no. Y10419). Map and p70 are highly
homologous, although the C termini differ, and Eap resembles p70 more.
The nucleotide sequence encoding another member of the Eap family of
proteins, a protein from strain Newman, also shows that these proteins
are similar (National Center for Biotechnology Information accession no. AJ132841); the deduced amino acid sequences of the N and C termini
were identical to those of the N and C termini of Eap purified by us
from strain Newman (14).
The observed binding of Eap to cells of S. aureus prompted
us to investigate which component(s) on the staphylococcal surface is
involved in Eap binding. We found that a 32-kDa neutral phosphatase (NPase) located on the surface of S. aureus is the major
component to which Eap binds, but other potential docking structures
were not excluded.
 |
MATERIALS AND METHODS |
Bacterial strains.
S. aureus Newman, RN3401
(20), and Phillips (18) were used in this study.
Purification of Eap and NPase.
Eap was purified from the
culture supernatant of strain Newman by affinity chromatography on
fibrinogen-Sepharose, followed by ion-exchange chromatography using a
MonoS column (Pharmacia, Uppsala, Sweden) as described previously
(15). To purify NPase, a 1-liter culture (routinely of
strain RN3401) was centrifuged, washed in phosphate-buffered saline
(PBS), and resuspended in 200 ml of 1 M LiCl. The proteins were
extracted for 2 h at 37°C with gentle shaking. After
centrifugation (5,000 × g for 15 min) the extracted
proteins were dialyzed against PBS to remove LiCl and applied to an
Eap-Sepharose column. Eap (5 mg) was coupled to 2 g of
CNBr-activated Sepharose 4B (Pharmacia) by using the recommended
procedure. The column was washed with several volumes of PBS to remove
unbound proteins, and bound proteins were eluted with PBS supplemented
with 1 M NaCl. The 32-kDa NPase that eluted was dialyzed against PBS
and chromatographed again on Eap-Sepharose. After dialysis against 40 mM phosphate buffer (pH 6.4) (A buffer), the protein was further
purified by fast protein liquid chromatography (FPLC) with a MonoS
ion-exchange column. Elution was done with a gradient from A buffer to
A buffer with 1 M NaCl. NPase eluted at 0.6 M NaCl.
The specificity of the Eap-Sepharose affinity chromatography procedure
was assessed. LiCl extract derived from a 200-ml culture was applied
several times. The effluent containing nonbound proteins was collected.
The proteins bound to the Eap-Sepharose were salt extracted as
described above, and the column was washed. The effluent was reapplied
to the column, and this procedure was repeated eight times. The eighth
salt extract contained no proteins.
Determination of amino acid sequence.
About 50 µg of NPase
in PBS that was purified by two rounds of Eap-Sepharose affinity
chromatography followed by FPLC was used. The sequence was determined
by the Protein Analysis Center, Department of Medical Biochemistry and
Biophysics, Karolinska Institutet, Stockholm, Sweden.
Capture enzyme-linked immunosorbent assay (ELISA).
Microtiter wells (Costar) were coated overnight with 100 µl of Eap,
fibrinogen (Sigma Chemical Co. St. Louis, Mo.), or fibronectin (Sigma)
in PBS at concentrations ranging from 1 to 180 µg/ml. Blocking was
done by adding 100 µl of 5% bovine serum albumin (BSA) in PBS for
1 h at 37°C. After washing, 100 µl of NPase (20 µg/ml) was
added, and the preparation was incubated for 1 h at 37°C. After
washing with 50 mM Tris buffer (pH 7.0), binding of NPase was
determined by adding 100 µl of para-nitrophenylphosphate (pNPP). pNPP tablets (Sigma) were dissolved in 50 mM Tris buffer (pH
7.0). Absorbance at 405 nm (A405) was measured
after 20 min.
NPase (100 µl) was also immobilized in microtiter wells at
concentrations ranging from 0.04 to 80 µg/ml in PBS plus 0.05%
Tween
20 (PBST). Blocking was done by adding 100 µl of 5% BSA
in PBS.
Either 100 µl of fibronectin (10 µg/ml) or 100 µl of fibrinogen
(5 µg/ml) in PBST was added, and the preparation was incubated
for
1 h at 37°C. After washing with PBST, binding of fibronectin
or
fibrinogen was determined by adding 100 µl of horseradish peroxidase
(HRP)-conjugated rabbit anti-fibronectin or anti-fibrinogen antibodies
(Dako, Glostrup, Denmark) diluted 1:1,000 in PBST. The preparation
was
incubated for 1 h at 37°C, and after washing with PBST the
color
reaction was developed with OPD tablets (Dako) as recommended
by the
manufacturer. The results were read at 495 nm. Background
values due to
binding of the HRP-conjugated antibodies directly
to the immobilized
NPase were obtained by omitting fibronectin
or fibrinogen. These values
were
subtracted.
Binding of human immunoglobulin G (IgG) to NPase was determined by
immobilizing NPase as described above and blocking it by
adding 100 µl of 5% gelatin in PBS and incubating the preparation
for 1 h
at 37°C. The following components (100 µl) in PBST were
added
consecutively with washing between additions: human IgG
(10 µg/ml;
Sigma), rabbit antibodies against human IgG gamma chain
(diluted 1:500;
Dako), and swine anti-rabbit IgG HRP-conjugated
antibodies (Dako). Each
preparation was incubated for 1 h at 37°C.
The color reaction
was developed with TMB (Dako) used according
to the instructions of the
manufacturer. The multiple layers of
IgG enhanced the signal (range,
1.1 to 2.1), although the background
level (when NPase coating was
omitted) was high (1.1).
Binding of NPase to S. aureus cells.
Cells of
S. aureus Newman (5 × 105 to 8 × 106 CFU) that were washed overnight in 50 mM Tris buffer
(pH 7.0) were mixed with 10 µg of NPase in 1 ml (total volume) of 50 mM Tris buffer (pH 7.0). The mixtures were incubated at 37°C for
1 h with shaking. The bacteria were then washed four times with
Tris buffer and resuspended in 120 µl of Tris buffer. The bacteria
were transferred to microtiter wells, and pNPP substrate was added. The
A405 was determined after 20 min. In control
experiments, in which NPase was omitted, the endogenous phosphatase
activity of the bacteria was determined and was found to be negligible
compared to the amounts added.
Binding of radioactive Eap to S. aureus cells.
Iodinated Eap (1 µg) was added to 108 CFU of S. aureus Newman in 750 µl of PBS. Various amounts of
nonradioactive Eap or NPase were added simultaneously. The mixtures
were incubated at room temperature for 1 h. The cells were washed
five times, and the radioactivity associated with the cells was
determined with a gamma counter.
Determination of the Kd for NPase and
Eap.
Microtiter wells were coated with 100 µl of Eap (80 µg/ml
in PBS) overnight and blocked by adding 100 µl of 2% BSA in PBS and
incubating the preparation for 1 h. After washing, increasing concentrations of NPase, ranging from 0.2 to 1.9 µM in 100 µl, were
added, and the preparations were incubated for 2 h. The unbound fractions of NPase were determined by transferring the preparations to
wells in another microtiter plate, in which the samples were serially
diluted. Phosphatase activity was determined by adding pNPP substrate
as described above. The dilution required to obtain a certain
absorbance value was determined, and by using standardized serial
dilutions of NPase the specific phosphatase activity per mole was
determined. After the plates were washed, the fractions of NPase which
had bound to Eap were determined with pNPP by comparison with the
standardized dilutions. The amount of nonspecific binding of NPase to
wells coated only with 2% BSA was below the limit of detection. A
Scatchard plot was obtained by plotting the number of bound molecules
per unbound concentration as a function of the number of bound
molecules. The dissociation constant (Kd) was
calculated by dividing the number of bound molecules by the number of
bound molecules per unbound concentration where the best-fit line
intercepted the x axis and y axis. In separate
experiments we found that Eap does not inhibit NPase.
 |
RESULTS |
Identification of NPase as a binding target for Eap.
In order
to find a cell surface target for Eap, an LiCl extract of S. aureus RN3401 was applied to an Eap-Sepharose column, and the
affinity-purified material was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE). A 32-kDa protein was
the major protein found by PAGE (Fig. 1,
lane C). This could have been due to a high affinity, a high level of
the protein, or both factors. The effluent from the Eap-Sepharose
column was collected and reelectrophoresed eight times with salt
elution and reequilibration of the column between cycles. No detectable proteins were bound to the Eap-Sepharose column after the last electrophoresis. The eighth effluent was devoid of the 32-kDa protein,
as shown in Fig. 1, lane B. The purified 32-kDa protein could be
further purified by reapplying it, after dialysis, to the Eap-Sepharose
column, which verified its affinity to Eap. The 32-kDa protein was also
found in strains Newman and Phillips but in smaller amounts (data not
shown).

View larger version (114K):
[in this window]
[in a new window]
|
FIG. 1.
Sodium dodecyl sulfate-PAGE. Lane A, proteins in an LiCl
extract before electrophoresis through an Eap-Sepharose column; lane B,
material in the flowthrough after eight rounds of affinity
chromatography on Eap-Sepharose, with elution between cycles; lane C,
NPase recovered from the Eap-Sepharose column after the first round of
affinity chromatography (the material was concentrated more than the
material in lanes A and B to show purity). The positions of molecular
weight markers (in thousands) are indicated on the right.
|
|
Purification of Eap from strain RN3401 by the fibrinogen-Sepharose
method followed by FPLC, as described in Materials and
Methods, showed
that strain RN3401 also produces Eap but produces
less than strain
Newman (data not
shown).
The 32-kDa protein was subjected to NH
2-terminal amino acid
analysis; 12 amino acids were identified
(NH
2-KSSAEVQQTQQA), and
these amino acids exhibited
identity with the amino acids of a
previously identified NPase
(
22). A search of a database (The
Institute for Genomic
Research;
http://www.tigr.org/tdb/tdb.html)
showed that the NPase
is synthesized with a typical 31-amino-acid
signal sequence for
secretion but no LPXTG for attachment to the
peptidoglycan
(
21). The sequence shows that there is an open
reading
frame encoding a 30,165-Da
protein.
The protein obtained with the Eap-Sepharose column was chromatographed
through a cation-exchange column, and the elution profile
for 0.6 M
NaCl was compatible with previous findings (
22). As
shown
below, this protein had phosphatase activity. Thus, we concluded
that
our 32-kDa protein was an NPase that was described previously
(
22).
The proportions of cell surface-associated NPase from strain RN3401 and
released NPase were determined by comparing the amounts
obtained from
LiCl extracts and from culture supernatants. Approximately
80% of all
NPase was found to be cell surface associated (i.e.,
in the LiCl
extract) (data not shown). Although less NPase was
produced by the
other strains, the proportion of cell surface-associated
NPase was the
same for all
strains.
Binding of NPase to Eap, fibrinogen, and fibronectin.
The
binding of NPase to Eap was confirmed by a capture ELISA in which
various concentrations of Eap, fibronectin, or fibrinogen were
immobilized in microtiter wells and then NPase was added. Figure
2A shows the binding of NPase, measured
as bound phosphatase activity, to Eap and fibronectin. In a similar
assay in which the components were added in the reverse order, binding
of fibronectin to various amounts of immobilized NPase was determined
(Fig. 2B). The antibodies used to detect fibronectin binding resulted
in minimal background binding to NPase in the control in which
fibronectin was omitted, although binding of IgG to NPase has been
reported previously (22). Such binding was demonstrated by
adding higher amounts of IgG to immobilized NPase, as shown in Fig. 2B.
Varying the amount of fibronectin or IgG revealed a dose-response
relationship (data not shown). No interaction between NPase and
fibrinogen was evident in any of the ELISA tests. Instead, binding of
the sticky fibrinogen molecules in the microtiter wells was blocked by
the NPase (Fig. 2B).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Capture of NPase with immobilized fibrinogen,
fibronectin, and Eap. Different concentrations of fibrinogen ( ),
fibronectin ( ), or Eap ( ) were used to coat microtiter wells to
which NPase (20 µg/ml) was added. Bound NPase activity was measured
based on the phosphatase activity. The results of a typical experiment
are shown. (B) Capture of fibronectin, fibrinogen, and IgG with
immobilized NPase. Different concentrations of NPase were used to coat
microtiter wells to which fibronectin (10 µg/ml), fibrinogen (5 µg/ml), or human IgG (10 µg/ml) was added. Binding of these
proteins was measured as described in Materials and Methods. Background
values for fibronectin binding (obtained by omitting fibronectin) were
subtracted, and the background value for IgG binding (obtained by
omitting NPase coating) was 1.1. The results of a typical experiment
are shown. Symbols: , fibronectin; , fibrinogen; , IgG.
|
|
Binding between NPase and Eap was also demonstrated in a
double-diffusion test performed with agarose. A precipitation band
was
observed between wells filled with Eap and NPase, and the
distance
between the precipitation band and the central well containing
NPase
was smaller with a higher concentration of Eap (Fig.
3).
This means that the interaction
between Eap and NPase results
in a lattice and can take place only in
an ordered form with a
nonrandom molar ratio, as is the case with an
antibody-antigen
reaction. Precipitation bands were also observed
between Eap and
fibronectin but not between NPase and fibrinogen or
fibronectin
(data not shown).

View larger version (142K):
[in this window]
[in a new window]
|
FIG. 3.
Double diffusion in agarose. The central well contained
NPase (120 µg/ml), and the peripheral wells contained Eap (well 1, no
Eap; well 2, 350 µg/ml; well 3, 700 µg/ml; well 4, 1,400 µg/ml).
|
|
Adding increasing concentrations of Eap, fibrinogen, or fibronectin to
a constant amount of immobilized or soluble NPase did
not reduce
the phosphatase activity (data not
shown).
Binding of NPase to cells of S. aureus.
As
mentioned above, the major portion of NPase is cell surface associated.
The interaction between cells of S. aureus and NPase was
shown by adding NPase to S. aureus Newman. By measuring the
phosphatase activity bound to the cells, we found that externally added
NPase, in addition to the endogenous NPase, could bind to the cells
(Fig. 4). Endogenous phosphatase activity
was not detectable in this assay when there was excess exogenous NPase
(data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Binding of NPase to S. aureus. Different
amounts of washed S. aureus cells were incubated with NPase
(10 µg/ml). The bacteria were washed, and the cell-associated
phosphatase activity was determined. The endogenous phosphatase
activity of the cells was insignificant. Mean values from four
experiments and standard errors are shown.
|
|
Binding of radiolabeled Eap to
S. aureus could be
competitively inhibited by unlabeled Eap (
15). However,
addition of NPase
enhanced the binding of Eap, as shown in Fig.
5.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of Eap or NPase on Eap binding to S. aureus. Radioactive Eap was added to S. aureus in the
presence of different concentrations of nonradioactive Eap or NPase.
The relative amounts of labeled Eap bound to the cells were then
determined. Symbols: , NPase; , Eap.
|
|
Determination of the Kd.
Increasing
amounts of NPase were added to immobilized Eap. The number of bound
molecules was plotted against the amount added (Fig.
6). A Scatchard analysis of the data
obtained gave a Kd value of approximately 0.5 µM (Fig. 6, inset). This value is close to the
Kd reported for clumping factor and fibrinogen
(11).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Determination of Kd. Different
concentrations of NPase were added to immobilized Eap, and the number
of bound molecules was calculated. The inset shows a Scatchard plot of
the data.
|
|
 |
DISCUSSION |
Adherence of S. aureus directly to eukaryotic cells is
considered an important feature of this organism. We have previously shown that adherence of S. aureus to eukaryotic cells is
enhanced by a secreted protein, Eap, which can bind both to S. aureus and to cells acting as adherence mediators. We therefore
set out to identify a possible target structure for Eap on the
bacterial cell surface that explains its rebinding. The number of
externally added Eap molecules which could bind per bacterial cell was
found to be more than 50,000, and because of a marked tendency of Eap to form aggregates, it is conceivable that clusters of Eap molecules bind to cells at an undefined site(s). Such a site(s) could be either a
highly specialized receptor or a structure(s) to which the sticky Eap
molecule could bind by nonspecific electrostatic forces. Our approach
for identifying a target structure was to use affinity chromatography
of surface-associated proteins using Sepharose-coupled Eap. If such an
affinity column was not saturated, different amounts of proteins with
different affinities would bind. If instead overloading was allowed,
the protein with the strongest binding and/or the most abundant protein
would win in a competition for a limited number of Eap sites on the
column. In the latter competitive situation, Eap was the best Eap
binder from strain Newman, but when strain RN3401 was examined, a
32-kDa protein was the best Eap binder. However, both of these strains contain both proteins, although they contain different amounts. Reelectrophoresis of the flowthrough several times resulted in depletion from the LiCl extract mainly of the NPase, as shown in Fig. 1
(compare lanes A and B). Thus, we concluded that a major target
structure for Eap on the S. aureus surface is the 32-kDa protein, although there may also be other targets not found in this
study. The identity of the 32-kDa protein and a previously described
NPase was shown by the identical NH2 termini, the
phosphatase activity, the binding to human IgG, the molecular size, and
the elution profile obtained during ion-exchange chromatography.
The interaction between Eap and the NPase was demonstrated in a capture
ELISA (Fig. 2A) and by precipitation bands formed in a double-diffusion
test (Fig. 3). A precipitation band was formed only when the two
proteins were mixed at an optimal concentration, showing that the
binding between Eap and NPase is not random aggregation or a monovalent
interaction. Both Eap and NPase have high isoelectric points (14,
22), which means that the binding is not due to a charge
interaction but rather is more specific. The Kd
(0.5 µM) is close to the value that has been reported for the
interaction between Clf and fibrinogen (11). Addition of
external NPase, which bound to the cells (Fig. 4), stimulated
association of Eap with the cells (Fig. 5), further suggesting that
NPase is a mediator of Eap attachment to the cell surface.
The interaction between Eap and NPase has at least two biological
implications. First, surface-associated NPase clearly serves as a
target for Eap on the bacterial cell surface, although Eap might also
bind to other bacterial surface structures not identified here. Second,
NPase not associated with the cell surface (in the cultures used in
this study this was about 20% of all NPase) can dock with
extracellular Eap; Eap is mainly found extracellularly (15). The NPase-Eap complex has multiple functions; it
adheres to fibronectin (both NPase and Eap adhere), fibrinogen,
prothrombin, and immunoglobulins, and it has phosphatase activity.
Since Eap strongly enhances the interaction between S. auerus and the host cell (15), a phosphatase attached
to the Eap molecule could influence subsequent events and affect the
host cell surface, which in turn could affect cell signaling,
phagocytosis, and bacterial internalization.
A double mutant of S. aureus lacking both genes for
fibronectin binding (fnbA and fnbB) was
constructed (5). We have observed residual binding to
fibronectin of this strain (16), and we also have observed
that the amount of fibronectin binding protein on the cell surface does
not correlate with the capacity to bind to fibronectin
(6). We suggest that this is due to the presence of
different amounts of NPase and bound Eap on the cell surface.
Furthermore, NPase has been shown to bind to rat and human IgG, IgM,
and IgA (22), and Yousif et al. speculated that NPase could be relevant for postinfectious sequelae. This effect could be
further enhanced by the binding of NPase to fibronectin reported here.
 |
ACKNOWLEDGMENTS |
This work was supported by The Swedish Medical Research Council
(grant K2000-16X-12218-04B) and by Biostapro AB.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Pathology and Immunology, Division of Clinical
Bacteriology, Huddinge University Hospital, F82, Karolinska Institutet,
S-141 86 Huddinge, Sweden. Phone: 46 8 58581169. Fax: 46 8 7113918. E-mail: jan-ingmar.flock{at}impi.ki.se.
 |
REFERENCES |
| 1.
|
Bodén, M., and J.-I. Flock.
1994.
Cloning and characterization of a gene for a 19 kDa fibrinogen binding protein from Staphylococcus aureus.
Mol. Microbiol.
12:599-606[CrossRef][Medline].
|
| 2.
|
Bodén, M., and J.-I. Flock.
1992.
Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman.
Microb. Pathog.
12:289-298[CrossRef][Medline].
|
| 3.
|
Braun, L.,
S. Dramsi,
P. Dehoux,
H. Bierne,
G. Lindahl, and P. Cossart.
1997.
In1B: an invasion protein of Listeria monocytogenes with a novel type of surface association.
Mol. Microbiol.
25:285-294[CrossRef][Medline].
|
| 4.
|
Fujigaki, Y.,
Y. Yousif,
T. Morioka,
S. Batsford,
A. Vogt,
A. Hishida, and M. Miyasaka.
1998.
Glomerular injury induced by cationic 70-kD staphylococcal protein; specific immune response is not involved in early phase in rats.
J. Pathol.
184:436-445[CrossRef][Medline].
|
| 5.
|
Greene, C.,
D. McDevitt,
P. Francois,
P. Vaudaux,
D. P. Lew, and T. Foster.
1995.
Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin binding proteins and studies on the expression of fnb genes.
Mol. Microbiol.
17:1143-1152[CrossRef][Medline].
|
| 6.
|
Hienz, S. A.,
M. Palma, and J.-I. Flock.
1996.
Insertional inactivation of the gene for collagen-binding protein has a pleiotropic effect on the phenotype of Staphylococcus aureus.
J. Bacteriol.
178:5327-5329[Abstract/Free Full Text].
|
| 7.
|
Jahreis, A.,
Y. Yousif,
J. A. Rump,
R. Dräger,
A. Vogt,
H. H. Peter, and M. Schlesier.
1995.
Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID).
Clin. Exp. Immunol.
100:406-411[Medline].
|
| 8.
|
Jönsson, K.,
D. McDevitt,
M. H. McGavin,
J. M. Patti, and M. Höök.
1995.
Staphylococcus aureus expresses a major histocompatibility complex class II analog.
J. Biol. Chem.
270:21457-21460[Abstract/Free Full Text].
|
| 9.
|
Mamo, W.,
M. Bodén, and J.-I. Flock.
1994.
Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonization of S. aureus in a mouse mastitis model.
FEMS Immunol. Med. Microbiol.
10:47-54[CrossRef][Medline].
|
| 10.
|
McDevitt, D.,
P. Francois,
P. Vaudaux, and T. J. Foster.
1995.
Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus.
Mol. Microbiol.
16:895-907[CrossRef][Medline].
|
| 11.
|
McDevitt, D.,
T. Nanavaty,
K. House-Pompeo,
E. Bell,
N. Turner,
L. McIntire,
T. J. Foster, and M. Höök.
1997.
Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen.
Eur. J. Biochem.
247:416-424[Medline].
|
| 12.
|
Moreillon, P.,
J. M. Entenza,
P. Francioli,
D. McDevitt,
T. J. Foster,
P. Francois, and P. Vaudaux.
1995.
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.
Infect. Immun.
63:4738-4743[Abstract].
|
| 13.
|
Ni Eidhin, D.,
S. Perkins,
P. Francois,
P. Vaudaux,
M. Höök, and T. Foster.
1998.
Clumping factor B (ClfB), a new surface located fibrinogen-binding adhesin of Staphylococcus aureus.
Mol. Microbiol.
30:245-257[CrossRef][Medline].
|
| 14.
|
Palma, M.
1999.
Fibrinogen binding proteins from Staphylococcus aureus. Ph.D. thesis.
Karolinska Institutet, Stockholm, Sweden.
|
| 15.
|
Palma, M.,
A. Haggar, and J.-I. Flock.
1999.
Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding specificity.
J. Bacteriol.
181:2840-2845[Abstract/Free Full Text].
|
| 16.
|
Palma, M.,
S. Nozohoor,
T. Schennings,
A. Heimdahl, and J.-I. Flock.
1996.
Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection.
Infect. Immun.
64:5284-5289[Abstract].
|
| 17.
|
Palma, M.,
D. Wade,
M. Flock, and J.-I. Flock.
1998.
Multiple binding sites in the interaction between fibrinogen and an extracellular fibrinogen binding protein from Staphylococcus aureus.
J. Biol. Chem.
273:13177-13181[Abstract/Free Full Text].
|
| 18.
|
Patti, J. M.,
T. Bremell,
D. Krajewska-Pietrasik,
A. Abdelnour,
A. Tarkowski,
C. Ryden, and M. Höök.
1994.
The Staphylococcus aureus collagen adhesion is a virulence determinant in experimental septic arthritis.
Infect. Immun.
62:152-161[Abstract/Free Full Text].
|
| 19.
|
Phonimdaeng, P.,
M. O'Reilly,
P. Nowlan,
A. J. Bramley, and T. J. Foster.
1990.
The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants.
Mol. Microbiol.
4:393-404[Medline].
|
| 20.
|
Poston, S. M.,
G. R. Glancey,
J. E. Wyatt,
T. Hogan, and T. J. Foster.
1993.
Co-elimination of mec and spa genes in Staphylococcus aureus and the effect of agr and protein A production on bacterial adherence to cell monolayer.
J. Med. Microbiol.
39:422-428[Abstract/Free Full Text].
|
| 21.
|
Schneewind, O.,
D. Mihaylova-Petkov, and P. Model.
1993.
Cell wall sorting signals in surface proteins of Gram-positive bacteria.
EMBO J.
12:4803-4811[Medline].
|
| 22.
|
Yousif, Y.,
E. Schiltz,
K. Okada,
S. Batsford, and A. Vogt.
1994.
Staphylococcal neutral phosphatase; a highly cationic molecule with binding properties for immunoglobulin.
APMIS
102:891-900[Medline].
|
Journal of Bacteriology, July 2001, p. 3999-4003, Vol. 183, No. 13
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.13.3999-4003.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Harraghy, N., Homerova, D., Herrmann, M., Kormanec, J.
(2008). Mapping the Transcription Start Points of the Staphylococcus aureus eap, emp, and vwb Promoters Reveals a Conserved Octanucleotide Sequence That Is Essential for Expression of These Genes. J. Bacteriol.
190: 447-451
[Abstract]
[Full Text]
-
Geisbrecht, B. V., Hamaoka, B. Y., Perman, B., Zemla, A., Leahy, D. J.
(2005). The Crystal Structures of EAP Domains from Staphylococcus aureus Reveal an Unexpected Homology to Bacterial Superantigens. J. Biol. Chem.
280: 17243-17250
[Abstract]
[Full Text]
-
Gutekunst, H., Eikmanns, B. J., Reinscheid, D. J.
(2004). The Novel Fibrinogen-Binding Protein FbsB Promotes Streptococcus agalactiae Invasion into Epithelial Cells. Infect. Immun.
72: 3495-3504
[Abstract]
[Full Text]
-
Harraghy, N., Hussain, M., Haggar, A., Chavakis, T., Sinha, B., Herrmann, M., Flock, J.-I.
(2003). The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology
149: 2701-2707
[Abstract]
[Full Text]
-
Heilmann, C., Thumm, G., Chhatwal, G. S., Hartleib, J., Uekotter, A., Peters, G.
(2003). Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology
149: 2769-2778
[Abstract]
[Full Text]
-
Haggar, A., Hussain, M., Lonnies, H., Herrmann, M., Norrby-Teglund, A., Flock, J.-I.
(2003). Extracellular Adherence Protein from Staphylococcus aureus Enhances Internalization into Eukaryotic Cells. Infect. Immun.
71: 2310-2317
[Abstract]
[Full Text]
-
Hussain, M., Haggar, A., Heilmann, C., Peters, G., Flock, J.-I., Herrmann, M.
(2002). Insertional Inactivation of eap in Staphylococcus aureus Strain Newman Confers Reduced Staphylococcal Binding to Fibroblasts. Infect. Immun.
70: 2933-2940
[Abstract]
[Full Text]
-
Hussain, M., Becker, K., von Eiff, C., Schrenzel, J., Peters, G., Herrmann, M.
(2001). Identification and Characterization of a Novel 38.5-Kilodalton Cell Surface Protein of Staphylococcus aureus with Extended-Spectrum Binding Activity for Extracellular Matrix and Plasma Proteins. J. Bacteriol.
183: 6778-6786
[Abstract]
[Full Text]
-
Hussain, M., Becker, K., von Eiff, C., Peters, G., Herrmann, M.
(2001). Analogs of Eap Protein Are Conserved and Prevalent in Clinical Staphylococcus aureus Isolates. CVI
8: 1271-1276
[Abstract]
[Full Text]